PRESENTATIONS & PUBLICATIONS


PRESENTATIONS

2006
SOT Annual Conference, March 2006

Poster Presentation
Pulmonary Biochemical Alterations Induced by Systemic Administration of Nitrogen Mustard
Presented by Nabil Elsayed, Ph.D.

2005
RAPS Annual Conference, October 2005
Track Session - Drugs
Preparation for FDA Advisory Panel and Other FDA Meetings

Session Leader: Margaret E. Hurley, M.D.

Speakers:  Igor Cerny, Pharm.D. - CDER/FDA, Robert M. Kirsch, RAC - Serono, Inc.

Sunrise Poster Session
Developing Risk Assessment Plans During Clinical Development and Post-Marketing

Presented by Dolores R. Massari, M.S., and Margaret E. Hurley, M.D.
DIA 41st Annual Meeting, June 2005

Poster Presentation
Understanding Risk Management Plans and Translating the Development Program Results
Presented by Susan M. Mondabaugh, Ph.D., and Margaret E. Hurley, M.D..

SOT Annual Conference, March 2005

Poster Presentation
Injury Dynamics Following Sublethal Blast Overpressure Exposures
Presented by Nabil Elsayed, Ph.D.

2004
RAPS Annual Conference, October 2004
Track Session - Drugs
What's New with 505(b)(2) Applications

Session Leader: Susan M. Mondabaugh, Ph.D.

Speakers:  Robert Dormer - Hyman, Phelps, McNamara, P.C., Kerstin Franzen - Pfizer, and Margaret E. Hurley, M.D.

Interactions with Healthcare Authorities:  Creating a Win-Win Environment
Session Leader: Kevin McKenna, AstraZeneca.

Speaker:  Susan M. Mondabaugh, Ph.D

Sunrise Poster Session
CMC Requirements for Herbal Drug Products

Presented by Susan M. Mondabaugh, Ph.D. and Jerry J. Kolaitis

Registration Patents and Exclusivity for 505(b)(2)
Presented by Mark E. Rosengarten, M.A. and Susan M. Mondabaugh, Ph.D.
SOT Annual Conference, March 2004

Poster Presentation
Injury Dynamics Following Sublethal Blast Overpressure Exposures
Presented by Nabil Elsayed, Ph.D.

2003

RAPS Annual Conference, October 2003

Session Speaker
Global  Development Programs: Does Multinational Harmonization Work?
Presented by Susan M. Mondabaugh, Ph.D.

Poster Presentation
Data-Driven CMC Review Process to Minimize Risk
Presented by Dolores R. Massari, M.S., Mark E. Rosengarten, M.A., Margaret E. Hurley, M.D., and Susan M. Mondabaugh, Ph.D.

DIA 39th Annual Meeting, June 2003

Poster Session
CMC Risk-based Product Reviews

Presented by Marshall A. Hayward, Ph.D.

Finding the Subtle Safety Signal
Presented by Margaret E. Hurley, M.D.

PUBLICATIONS

2006

RAPS Focus Magazine, March 2006

The Role of Regulatory Affairs in Due Diligence for Late-Stage Products
By Margaret E. Hurley, M.D. and Susan M. Mondabaugh, Ph.D.

2005

RAPS Focus Magazine, November 2005

Are You Ready for the Risk Management Paradigm Shift?
By Susan M. Mondabaugh, Ph.D.

Risk Management - Translating the Results of the Development Program in Today's Regulatory Environment
By Susan M. Mondabaugh, Ph.D., Dolores R. Massari, M.S., and Margaret E. Hurley, M.D.

RAPS Focus Magazine, June 2005

How to Investigate Out-of-Specification Results
By Jerry J. Kolaitis and Susan M. Mondabaugh, Ph.D.

2004

RAPS Focus Magazine, October 2004

A Data-Driven CMC Review Process to Minimize Risk
By Dolores R. Massari, M.S., Glenn A. Diegnan, Ph.D., Margaret E. Hurley, M.D., Mark E. Rosengarten, M.A., and Susan M. Mondabaugh, Ph.D.

RAPS Focus Magazine, May 2004

The Nuts and Bolts of 505(b)(2) Applications
By Margaret E. Hurley, M.D.

Successfully Navigating the 505(b)(2) Regulatory Maze
By Susan M. Mondabaugh, Ph.D.

To "(b)(2)" or Not to "(b)(2)"?  When a 505(b)(2) is Not an ANDA
By Dolores R. Massari, M.S.

Are You Protected?  Are You Excluded?  Understanding Patent Certification and Exclusivity Incentives for 505(b)(2) NDAs
By Mark E. Rosengarten, M.S.

2002

RAPS Focus Magazine, April 2002

ICH Update: The Common Technical Document
By Susan M. Mondabaugh, Ph.D.


One Main Street  Chatham, NJ 07928 USA  Phone: 1.973.635.9898  Fax: 1.973.635.9881



Hit Counter